The Centers for Disease Control and Prevention Friday awarded $2.4 million in funding to Chicago, Houston, New York City, Philadelphia and Los Angeles County to enhance their information gathering to rapidly detect microcephaly and other birth defects caused by Zika virus. The funding, which follows similar awards last month to 40 states and territories, also will help the recipients refer infants and families to appropriate health and social services, and monitor health and developmental outcomes of children affected by Zika. Last week, the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response awarded $19.8 million to develop a Zika vaccine for use in the United States. To date, ASPR’s Biomedical Advanced Research and Development Authority has awarded more than $76 million to develop Zika vaccines, diagnostics, blood screening tests and pathogen reduction technologies.

Related News Articles

Headline
The Food and Drug Administration Thursday approved the first blood donor screening test for Zika virus. The agency last year recommended blood centers screen…
Headline
Eliminating the Medicaid Institutions for Mental Disease exclusion for adults under age 65 would help improve access to treatment for those with severe or…
Headline
More than 704,000 people arrived alive at a hospital emergency department for treatment of a firearm-related injury between 2006 and 2014, resulting in an…
Headline
The Centers for Disease Control and Prevention today issued recommendations to help health care providers and laboratories prevent the spread of Candida auris…
Headline
The Centers for Disease Control and Prevention today deactivated its emergency operations center for Zika virus. “Since the 2016 EOC activation for Zika…
Headline
An estimated 92% of hospital workers report receiving a flu vaccine for the 2016-17 flu season, compared with 76% of ambulatory care workers and 68% of long-…